Carbidopa and Levodopa Extended-Release Capsules and Emend Intravenous
Determining the interaction of Carbidopa and Levodopa Extended-Release Capsules and Emend Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Extended-Release Capsules-Emflaza
- Carbidopa and Levodopa Extended-Release Capsules-Emflaza (Deflazacort Oral Suspension)
- Carbidopa and Levodopa Extended-Release Capsules-Emflaza (Deflazacort Tablets)
- Carbidopa and Levodopa Extended-Release Capsules-Emicizumab
- Carbidopa and Levodopa Extended-Release Capsules-Emicizumab-kxwh
- Carbidopa and Levodopa Extended-Release Capsules-Emicizumab-kxwh Subcutaneous
- Emend Intravenous-Carbidopa and Levodopa Extended-Release Tablets
- Emend Intravenous-Carbidopa and Levodopa ODT
- Emend Intravenous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Emend Intravenous-Carbidopa and levodopa Route Not Applicable
- Emend Intravenous-Carbidopa and Levodopa Tablets
- Emend Intravenous-Carbidopa Tablets